Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmuth Kolb

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|February 19, 2020
Correction to Discovery of <i>N</i>-(4-[<sup>18</sup>F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging TracerFrederik J R Rombouts, Lieven Declercq, José-Ignacio Andrés, et al.
Journal of Medicinal Chemistry|February 28, 2019
Discovery of N-(4-[<sup>18</sup>F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging TracerFrederik J R Rombouts, Lieven Declercq, José-Ignacio Andrés, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community cohortsWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Nature Communications|April 5, 2020
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's diseaseShorena Janelidze, Erik Stomrud, Ruben Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community studiesWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Diabetes|October 23, 2009
Insulin causes hyperthermia by direct inhibition of warm-sensitive neuronsManuel Sanchez-Alavez, Iustin V Tabarean, Olivia Osborn, et al.
EJNMMI Research|July 5, 2018
PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjectsErica M Richards, Paolo Zanotti-Fregonara, Masahiro Fujita, et al.
JAMA Neurology|January 19, 2021
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical TrialReisa Sperling, David Henley, Paul S Aisen, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker TestsNoëlle Warmenhoven, Gemma Salvadó, Shorena Janelidze, et al.
Brain : a Journal of Neurology|October 29, 2024
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker testsNoëlle Warmenhoven, Gemma Salvadó, Shorena Janelidze, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|February 19, 2020
Correction to Discovery of <i>N</i>-(4-[<sup>18</sup>F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging TracerFrederik J R Rombouts, Lieven Declercq, José-Ignacio Andrés, et al.
Journal of Medicinal Chemistry|February 28, 2019
Discovery of N-(4-[<sup>18</sup>F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging TracerFrederik J R Rombouts, Lieven Declercq, José-Ignacio Andrés, et al.
Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community cohortsWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Nature Communications|April 5, 2020
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's diseaseShorena Janelidze, Erik Stomrud, Ruben Smith, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2025
Cross-cohort validation and cutpoint estimation of the Janssen plasma p-tau217+ assay in predominantly cognitively normal community studiesWasiu G Balogun, Xuemei Zeng, Gallen Triana-Baltzer, et al.
Diabetes|October 23, 2009
Insulin causes hyperthermia by direct inhibition of warm-sensitive neuronsManuel Sanchez-Alavez, Iustin V Tabarean, Olivia Osborn, et al.
EJNMMI Research|July 5, 2018
PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjectsErica M Richards, Paolo Zanotti-Fregonara, Masahiro Fujita, et al.
JAMA Neurology|January 19, 2021
Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical TrialReisa Sperling, David Henley, Paul S Aisen, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
A Comprehensive Head-to-Head Comparison of Key Plasma Phosphorylated Tau 217 Biomarker TestsNoëlle Warmenhoven, Gemma Salvadó, Shorena Janelidze, et al.
Brain : a Journal of Neurology|October 29, 2024
A comprehensive head-to-head comparison of key plasma phosphorylated tau 217 biomarker testsNoëlle Warmenhoven, Gemma Salvadó, Shorena Janelidze, et al.
Pageof 4